MedTrace Logo

Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

NCT03261128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-01-29

No results posted yet for this study

Summary

Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Conditions

  • 75 Years Old and More
  • Cancer
  • Chemotherapy

Interventions

OTHER

Self-questionnaire

Filling of a self-questionnaire before each chemotherapy cure

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • VALERO SV SIMON, Doctor · CHU Poitiers

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-21
Primary Completion
2018-09-11
Completion
2018-12-05

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03261128 on ClinicalTrials.gov